Evenamide could be a potential breakthrough treatment in the management of treatment-resistant schizophrenia (TRS) patients

4 Likes

Good news. Let’s hope they move to a double-blind study soon.

1 Like

No USA trials yet. I hope phase 3 includes USA.

2 Likes